Nurse Practitioner, Adult Health · Washington, DC
NPI
1477582138
Since 2006
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
3800 Reservoir Rd NW
Washington, DC, 20007
Phone (202) 444-8525
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
1,036 prescriptions
Company payments, 2025
$2,323
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Barbara Wilmarth prescribed most often to Medicare patients was Rytary (Carbidopa/Levodopa), with 229 prescriptions and refills. In total Barbara Wilmarth wrote 1,036 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-12.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rytary Carbidopa/Levodopa | 229 | 497 | 72 | $275K |
| Rasagiline Mesylate Generic | 124 | 330 | 46 | $27K |
| Nuplazid Pimavanserin Tartrate | 70 | 106 | 18 | $513K |
| Nourianz Istradefylline | 67 | 133 | 24 | $246K |
| Rivastigmine Generic | 63 | 160 | 25 | $18K |
| Donepezil Hcl Generic | 52 | 120 | 18 | $738 |
| Escitalopram Oxalate Generic | 46 | 104 | 15 | $858 |
| Clonazepam Generic | 44 | 92 | 23 | $943 |
| Memantine Hcl Generic | 38 | 90 | 15 | $1,546 |
| Gocovri Amantadine Hcl | 35 | 71 | 13 | $189K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 31 | 81 | 13 | $651 |
| Crexont Carbidopa/Levodopa | 27 | 68 | 18 | $31K |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 16 | 30 | Under 11 | $2,475 |
| Pyridostigmine Bromide Generic | 15 | 27 | Under 11 | $534 |
| Xadago Safinamide Mesylate | 15 | 45 | Under 11 | $46K |
Brand drugs: 548 claims; generic drugs: 488 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barbara Wilmarth $2,323 ($2,323 in general payments such as food, travel and fees) from 11 companies. The largest payer was Abbvie Inc. with $587.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 34 | $587 |
| Supernus Pharmaceuticals, Inc. SUPN | 7 | $408 |
| Amneal Pharmaceuticals LLC AMRX | 16 | $284 |
| MDD US Operations, LLC | 3 | $276 |
| ACADIA Pharmaceuticals Inc ACAD | 13 | $220 |
| Teva Pharmaceuticals USA, Inc. TEVA | 7 | $156 |
| Merz Pharmaceuticals, LLC | 6 | $133 |
| Eisai Inc. 4523.T | 5 | $92.78 |
| Abbott Laboratories ABT | 4 | $80.46 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $48.8 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.